Merck obesity drug shows weight loss in study (Reuters)

Reuters - Merck & Co said on Monday that patients on its experimental obesity drug lost more than twice as much weight as those on a placebo in a late-stage clinical study.

More: continued here

You can respond, or trackback from your own site.